Twitter | Search | |
Search Refresh
National Cancer Institute Aug 12
What is a tumor marker? It is anything present in or produced by cancer cells or other cells in response to cancer or certain noncancerous conditions that provides information about a cancer:
Reply Retweet Like
Matthias Mann Lab Apr 8
You can download the poster of our discovery review () in blood plasma here:
Reply Retweet Like
Henning Willers, MD Aug 12
It is kind of amazing. TP53 was named Molecule of the Year by back in 1993. Some 26 years later, it's still at the forefront of research, with lots of potential as a predictive/prognostic .
Reply Retweet Like
jobim2019 Jul 4
This afternoon Keynote speaker, on structured feature selection.
Reply Retweet Like
NCI Treatment 11h
The Division of Cancer Treatment & Diagnosis' Clinical Pharmacodynamic Biomarkers Program develops essential assays. If you perform clinical or preclinical pharmacodynamic studies, see the validated assays, SOPs, & reagent sources here:
Reply Retweet Like
Tom Driedonks Jul 1
My. Thesis. Is. Finished! "Decoding genetic messages in released by immune cells - lessons for applications" I wish I could post a different pic, of the prof and me holding a pile of paper, but this is the digital age so you will have to do with this one instead.
Reply Retweet Like
Rheumatology & Rheumatology Advances in Practice Sep 17
Our September edition includes a piece of original research evaluating a synovial fluid to distinguish sepsis from inflammatory joint diseases. Does calprotectin offer diagnostic value? Read the paper here:
Reply Retweet Like
Jason Karlawish May 2
Assisted Death and Dementia: more coverage of our P3MB paper on PAD in defined - there is a constituency
Reply Retweet Like
Prof Mark Hutchinson Jun 20
Want to join my team in Australia to conduct fundamental and translational pain research? We are hiring!! Please share.
Reply Retweet Like
Jeff Schwimmer 2h
Free author's copy of our article, Microbiome Signatures Associated with Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease. Available now in
Reply Retweet Like
Labo for Thrombosis Research Jul 7
Interesting talk by Elien Roose from our lab! Using ADAMTS13 conformation as a biomarker to discriminate iTTP
Reply Retweet Like
Don Sin Jul 13
Really nice study in , showing that airway bacterial load may represent a for therapeutic responses to an .
Reply Retweet Like
Atara Posner Sep 16
ctDNA as a for sooo useful for: 1. Early detection 2. Tracking tumour burden over time (eg post surgery) 3. Tracking tumour evolution 4. Easy access over biopsies
Reply Retweet Like
Sébastien COURAUD Jun 7
Our last paper with and deal with mutant NSCLC. A cohort derived from the global france study. Cc
Reply Retweet Like
Raphael Gottardo 📊🧪🖥️ Jul 13
New tool for high-dimensional cytometry data from my lab . Fully data-driven. Thanks Evan Greene and . Great collaboration with and the , application to discovery.
Reply Retweet Like
Bone & Joint Journal Jun 13
α-defensin is a which has been described as having a high degree of accuracy in the diagnosis of periprosthetic joint ; recent study compares the accuracy of the laboratory-based α-defensin immunoassay and the lateral flow test kit
Reply Retweet Like
Patty Watkins Jun 13
Toasting great stable report from thank you for testing for my and the effective aka which approved 11/18. !😇
Reply Retweet Like
Andrea Apolo, MD May 10
Reply Retweet Like
Genentech Aug 28
Replying to @genentech
With the help of testing, researchers are developing new targeted therapies that can treat many cancers, regardless of type or where they’re found in the body. Read more:
Reply Retweet Like
ALKLungCancer May 19
Brought to you by testing and targeted therapy! 5 Year Brandi has gotten married and just gave birth to her second child ALL while battling Stage 4 Lung Cancer! THIS is possible! with lung cancer! Help Share
Reply Retweet Like